Retraction: Mast Cells Express Novel Functional IL-15 Receptor α Isoforms

We wish to retract the article titled “Mast Cells Express Novel Functional IL-15 Receptor α Isoforms” by Elena Bulanova, Vadim Budagian, Zane Orinska, Hans Krause, Ralf Paus, and Silvia Bulfone-Paus, The Journal of Immunology , 2003, 170: [5045–5055][1]. This retraction follows a formal

[1]  K. Weinberg,et al.  The Common γ Chain (γc) Is a Required Signaling Component of the IL-21 Receptor and Supports IL-21-Induced Cell Proliferation via JAK3† , 2002 .

[2]  J. Wedemeyer,et al.  Analyzing the Roles of Mast Cells and Basophils in Host Defense and Other Biological Responses , 2002, International journal of hematology.

[3]  R. Paus,et al.  The IL-15Rα Chain Signals Through Association with Syk in Human B Cells1 , 2001, The Journal of Immunology.

[4]  A. Masuda,et al.  Interleukin-15 Prevents Mouse Mast Cell Apoptosis through STAT6-mediated Bcl-xL Expression* , 2001, The Journal of Biological Chemistry.

[5]  J. Lowenthal,et al.  Measurement of lymphokine receptors. , 2001, Current protocols in immunology.

[6]  M. Babina,et al.  Mast cells as initiators of immunity and host defense , 2001, Experimental dermatology.

[7]  X. P. Liu,et al.  Treatment of allergic asthma by targeting janus kinase 3-dependent leukotriene synthesis in mast cells with 4-(3', 5'-dibromo-4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline (WHI-P97). , 2000, The Journal of pharmacology and experimental therapeutics.

[8]  A. Gaggero,et al.  IL-15/IL-15Rα intracellular trafficking in human melanoma cells and signal transduction through the IL-15Rα , 2000, Oncogene.

[9]  M. Kubo,et al.  Interleukin-15 Induces Rapid Tyrosine Phosphorylation of STAT6 and the Expression of Interleukin-4 in Mouse Mast Cells* , 2000, The Journal of Biological Chemistry.

[10]  J. Bradley,et al.  Selective Blockade of IL-15 by Soluble IL-15 Receptor α-Chain Enhances Cardiac Allograft Survival1 , 2000, The Journal of Immunology.

[11]  Kotaro Suzuki,et al.  Role of common cytokine receptor γ chain (γc)– and Jak3-dependent signaling in the proliferation and survival of murine mast cells , 2000 .

[12]  K. Asadullah,et al.  Inhibition of Keratinocyte Apoptosis by IL-15: A New Parameter in the Pathogenesis of Psoriasis?1 , 2000, The Journal of Immunology.

[13]  S. Dubois,et al.  Subunit structure of the high and low affinity human interleukin-15 receptors. , 2000, European cytokine network.

[14]  P. Morrissey,et al.  Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice , 2000, The Journal of experimental medicine.

[15]  F. Magrangeas,et al.  Natural Splicing of Exon 2 of Human Interleukin-15 Receptor α-Chain mRNA Results in a Shortened Form with a Distinct Pattern of Expression* , 1999, The Journal of Biological Chemistry.

[16]  F. Uckun,et al.  Targeting Janus Kinase 3 in Mast Cells Prevents Immediate Hypersensitivity Reactions and Anaphylaxis* , 1999, The Journal of Biological Chemistry.

[17]  R. Paus,et al.  Death deflected: IL‐15 inhibits TNF‐α‐mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL‐15Rα chain , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  M. Zucca,et al.  Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15. , 1999, Blood.

[19]  M. Sherman,et al.  IL-4 preferentially activates a novel STAT6 isoform in mast cells. , 1999, Journal of immunology.

[20]  T. Dassopoulos,et al.  IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. , 1998, Immunity.

[21]  R. Paus,et al.  IL‐15‐IgG2b fusion protein accelerates and enhances a Th2 but not a Th1 immune response in vivo, while IL‐2‐IgG2b fusion protein inhibits both , 1998, European journal of immunology.

[22]  W. Fiers,et al.  Quiescence-inducing and antiapoptotic activities of IL-15 enhance secondary CD4+ T cell responsiveness to antigen. , 1998, Journal of immunology.

[23]  J. Chung,et al.  Function of the human interleukin 4 receptor (IL-4R)-derived acidic motif revealed by cytoplasmic domain chimeras of the IL-4R alpha chain and the IL-2R beta chain. , 1998, Cytokine.

[24]  J. Satoh,et al.  Interleukin-15, a T-cell growth factor, is expressed in human neural cell lines and tissues , 1998, Journal of the Neurological Sciences.

[25]  R. Paus,et al.  Interleukin-15 protects from lethal apoptosis in vivo , 1997, Nature Medicine.

[26]  R. Zambello,et al.  Interleukin-15: a novel cytokine with regulatory properties on normal and neoplastic B lymphocytes. , 1997, Leukemia & lymphoma.

[27]  R. Paus,et al.  Differential regulation of human T lymphoblast functions by IL-2 and IL-15. , 1997, Cytokine.

[28]  T. Waldmann,et al.  Identification of a novel receptor/signal transduction pathway for IL‐15/T in mast cells , 1996, The EMBO journal.

[29]  E. Berenstein,et al.  Transfection of Syk protein tyrosine kinase reconstitutes high affinity IgE receptor-mediated degranulation in a Syk-negative variant of rat basophilic leukemia RBL-2H3 cells , 1996, The Journal of experimental medicine.

[30]  A. Sher,et al.  Induction and regulation of IL-15 expression in murine macrophages. , 1996, Journal of immunology.

[31]  N. Copeland,et al.  Functional Characterization of the Human Interleukin-15 Receptor αChain and Close Linkage of IL15RA and IL2RA Genes (*) , 1995, The Journal of Biological Chemistry.

[32]  T. Huff,et al.  Differential responsiveness of purified mouse c-kit+ mast cells and their progenitors to IL-3 and stem cell factor. , 1995, Journal of immunology.

[33]  R. Rees,et al.  Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[34]  R. Paxton,et al.  IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. , 1995, Journal of immunology.

[35]  M. Caligiuri,et al.  Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor , 1994, The Journal of experimental medicine.

[36]  B. Nelson,et al.  Cytoplasmic domains of the interleukin-2 receptor β and γ chains mediate the signal for T-cell proliferation , 1994, Nature.

[37]  T. Waldmann,et al.  A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[38]  W. Leonard,et al.  The Molecular Basis of X‐Linked Severe Combined Immunodeficiency: The Role of the Interleukin‐2 Receptor γ Chain as a Common γ Chain, γc , 1994, Immunological reviews.

[39]  W. Schaffner,et al.  Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. , 1989, Nucleic acids research.

[40]  T. Waldmann,et al.  The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. , 1999, Annual review of immunology.

[41]  J. Giri.  Identification and cloning of a nobel IL - 15 binding protein that is strucurally related to the αchain of the IL - 2 receptor. , 1995 .